Positive results from multi-centre, prospective clinical trial presented at AAD
Michelson Diagnostics to launch enhanced software for VivoSight OCT scanner
Volume purchase order of Axsun Technologies Swept Laser Engine
MDL targets Malignant Melanoma with €2.3M EU Funding
£1.98 Million Financing for MD
OneMedForum14 in San Francisco
Our First VivoSight Newsletter
Michelson Diagnostics wins Regulatory Approval for VivoSight OCT Scanner in Australia
Study shows VivoSight OCT could help Eyelid Cancer Surgery